Oriza Equity Investment is a state-backed investment firm founded in 2001 in Suzhou, China. Sponsored by Suzhou Industrial Park, the company oversees more than 120 billion yuan in assets. It supports the growth of small and mid-sized enterprises through a mix of equity and debt financing. Headquartered in Suzhou with an international office in California, the firm maintains a long-term perspective on investments and manages a range of venture capital and private equity vehicles. Over its history, the firm has completed more than 1,500 direct investments and backed over 100 companies that reached public markets.
The firm allocates capital across sectors such as technology, healthcare, and advanced materials, operating specialized platforms that cater to various stages of company development. One platform funds startups from seed through expansion, focusing on novel manufacturing processes, renewable energy components, and battery materials. A direct investment arm backs strategic emerging industries like biomedicine and integrated circuits, while a U.S. subsidiary sources early-stage opportunities in the global tech market. In addition, a fund-of-funds division partners with other investors to deploy primary and secondary commitments, adapting to market shifts with select buyout positions.
Oriza Equity Investment places emphasis on clean technology and battery-related solutions within its early-stage vehicle. Its portfolio features companies that enhance battery longevity and safety, develop flexible energy storage materials, and advance green hydrogen production techniques. Notable examples include Iontra, which offers diagnostics to extend rechargeable cell life; Anthro Energy, recognized for high-performance flexible cells; and Ecolectro, focused on sustainable hydrogen catalysts. By combining sector expertise with patient capital, the firm seeks to foster innovations that contribute to lower emissions and more resilient energy infrastructure.
